viernes, 14 de noviembre de 2025

Neoadjuvant Nivolumab in NSCLC -- Follow-up Study Confirms Lasting Benefit Mark G. Kris, MD

https://www.medscape.com/viewarticle/neoadjuvant-nivolumab-nsclc-follow-study-confirms-lasting-2025a1000uon

No hay comentarios:

Publicar un comentario